Introduction
The association between dermatitis herpetiformis (DH) and a gluten-sensitive enteropathy (GSE) is now widely accepted (Katz & Strober 1978 , Fry 1979 . Patients adhering to a strict gluten-free diet (GFD) can reduce their dapsone requirement (Fry et al. 1973) , and in many cases, a GFD alone results in remission of both skin and gut lesions. However, circulating antibodies to gliadin (the active component of wheat gluten; Kasarda et al. 1976 ) have only been found in a minority of DH patients consuming a normal gluten-containing diet (Menzel et al. 1978 , Huff et al. 1979 .
Based on our observation that gliadin binds selectively in vitro to reticulin fibres in cryostat sections of mammalian tissue (Unsworth, Johnson et al. 1981) , we have developed a simple new immunofluorescent screening test for anti-gliadin antibodies (AGA) (Unsworth, Manuel et al. 1981) which compares favourably with the more established ELISA test for AGA. (Unsworth, Leonard, Holborow & Fry, in preparation) .
New screening test for AGA An aqueous solution of gliadin (0.1 mg/ml) is prepared as described previously (Unsworth, Manuel et al. 1981) , and incubated for 30 minutes at room temperature on cryostat sections (6 gm) of composite rat tissue (Johnson et al. 1978) (kidney, liver and stomach). Unbound wheat protein is then washed away in a bath containing phosphate buffered saline pH 7.2, and such gliadin-treated tissue sections are then used to detect AGA in patients' sera by indirect immunofluorescence (Johnson et al. 1978) , applying fluorescein conjugated sheep antisera to human immunoglobulin (Wellcome Reagents Ltd) as the final step. AGA-positive serum samples do not react with normal (untreated) rat tissue sections, but bind to gliadin-treated tissue sections to give a pattern of fluorescence which is almost indistinguishable from that given by anti-reticulin antibody (ARA) ( Figure 1 ).
Case report
Mr M J, aged 63 years, has had a nine-year history of itchy blisters, predominantly on the elbows and buttocks. A diagnosis of DH was based on the clinical and histological features, and on the finding of granular deposits of IgA in biopsies of on alternate days to control his rash. A small intestinal biopsy showed total villous atrophy and an elevated intra-epithelial cell lymphocyte count of 406 (normal below 200). A serum sample taken on the same day as the gut biopsy was negative for ARA and other autoantibodies by conventional indirect immunofluorescence on normal rat tissue sections, but when retested on gliadin-treated rat tissue sections gave bright reticulin staining, confirming the presence of AGA with a titre of 1/200, and of IgG and IgA class.
Discussion
The case reported here illustrates the presence of circulating AGA in DH. In a recent study we screened sera from 55 adults with DH of whom 26 had been adhering to a strict GFD for at least two years (Unsworth, Leonard, Holborow & Fry, in preparation). High titres of AGA were found only in patients treated solely with dapsone, and were closely related to the severity of the enteropathy. With only one exception, AGA were not found in patients on a strict GFD, even in low titre. In a previous study of children with untreated coeliac disease (Unsworth, Manuel et al. 1981) , and therefore a flat small intestinal mucosa, all cases were found to have high titres of serum AGA, which disappeared after commencement of a GFD, and reappeared on challenge. Hence screening sera for AGA promises to be a useful indicator of severe small intestinal villous atrophy in DH.
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Addenbrooke's Hospital, Cambridge CB2 2QQ A case of thyrotoxicosis presenting with choreoathetoid movements and a severe myopathy with bulbar involvement is described. Choreoathetosis has only occasionally been reported in thyrotoxicosis, and bulbar involvement in chronic thyrotoxic myopathy is rare. This case is unusual in presenting with both these complication which resolved completely after conventional drug treatment of the thyrotoxicosis.
Case report A 21-year-old man presented with a two month history of psychological disturbance, dysarthria, nasal regurgitation of fluids, generalized weakness, and involuntary movements. He also complained of thirst, polyuria, vomiting, heat intolerance, and had lost 15 kg in weight. There was no family history of thyroid disease or neurological disorder.
He was emaciated and unable to walk due to generalized muscle wasting. He had bulbar weakness, but no other features of myasthenia gravis, and choreoathetoid movements of his face and limbs, which were more severe on attention. There was a tachycardia of 100/min with hyperdynamic circulation, and moderate soft diffuse enlargement of the thyroid gland with a loud systolic bruit, lid retraction and lid lag, but no exophthalmos or ophthalmoplegia. All tendon reflexes were very brisk.
The following investigations were carried out: serum calcium 2.80 mmol/l (normal range 2.0-2.6), phosphate 1.63 mmol/l (normal range 0.8-1.4), bilirubin 11 smol/l, alkaline phosphatase 130 U/1, (normal range 30-92), gulamate pyruvate transaminase 64 U/1, (normal range 7-40), albumin 44 g/l, parathormone < 40 pg/ml (normal < 120), 25-hydroxy cholecalciferol 3.4 ng/ml (low normal); urinary calcium excretion 18.7 mmol/24 h (normal < 10) and urinary phosphate excretion 49.7 mmol/24 h (normal range 22-32). Serum thyroxine was > 300 nmol/l (normal range 55-144), triiodothyronine> 7.0 nmol/l (normal range 1.0-2.8) and antithyroid microsomal antibodies were positive in a titre of 1/100. Electromyography of the right deltoid muscle showed evidence of a myopathy, but microscopic examination of a biopsy of the left deltoid muscle
